{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:14:06Z","timestamp":1787062446336,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T00:00:00Z","timestamp":1523923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Uppsala Clinical Research Center"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00392-018-1252-0","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T01:52:52Z","timestamp":1523929972000},"page":"816-823","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Stent thrombosis rates the first year and beyond with new- and old-generation drug-eluting stents compared to bare metal stents"],"prefix":"10.1007","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8378-3869","authenticated-orcid":false,"given":"Christoph","family":"Varenhorst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Lindholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Sarno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran","family":"Olivecrona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Lagerqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,17]]},"reference":[{"key":"1252_CR1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMra1112570","volume":"366","author":"EG Nabel","year":"2012","unstructured":"Nabel EG, Braunwald E (2012) A tale of coronary artery disease and myocardial infarction. N Engl J Med 366:54\u201363","journal-title":"N Engl J Med"},{"key":"1252_CR2","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMra1210816","volume":"368","author":"GG Stefanini","year":"2013","unstructured":"Stefanini GG, Holmes DR Jr. (2013) Drug-eluting coronary-artery stents. N Engl J Med 368:254\u2013265","journal-title":"N Engl J Med"},{"key":"1252_CR3","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa032441","volume":"350","author":"GW Stone","year":"2004","unstructured":"Stone GW, Ellis SG, Cox DA, Hermiller J, O\u2019Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME, Investigators T-I (2004) A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350:221\u2013231","journal-title":"N Engl J Med"},{"key":"1252_CR4","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1056\/NEJMoa035071","volume":"349","author":"JW Moses","year":"2003","unstructured":"Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O\u2019Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE, Investigators S (2003) Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349:1315\u20131323","journal-title":"N Engl J Med"},{"key":"1252_CR5","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1161\/01.CIR.0000116202.41966.D4","volume":"109","author":"R Virmani","year":"2004","unstructured":"Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, Mihalcsik L, Tespili M, Valsecchi O, Kolodgie FD (2004) Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109:701\u2013705","journal-title":"Circulation"},{"key":"1252_CR6","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.amjmed.2006.01.023","volume":"119","author":"AA Bavry","year":"2006","unstructured":"Bavry AA, Kumbhani DJ, Helton TJ, Borek PP, Mood GR, Bhatt DL (2006) Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. Am J Med 119:1056\u20131061","journal-title":"Am J Med"},{"key":"1252_CR7","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","volume":"369","author":"J Daemen","year":"2007","unstructured":"Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Juni P, Sianos G, Hellige G, van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW (2007) Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369:667\u2013678","journal-title":"Lancet"},{"key":"1252_CR8","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMoa067722","volume":"356","author":"B Lagerqvist","year":"2007","unstructured":"Lagerqvist B, James SK, Stenestrand U, Lindback J, Nilsson T, Wallentin L, Group SS (2007) Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 356:1009\u20131019","journal-title":"N Engl J Med"},{"key":"1252_CR9","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1056\/NEJMoa0809902","volume":"360","author":"SK James","year":"2009","unstructured":"James SK, Stenestrand U, Lindback J, Carlsson J, Schersten F, Nilsson T, Wallentin L, Lagerqvist B, Group SS (2009) Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden. N Engl J Med 360:1933\u20131945","journal-title":"N Engl J Med"},{"key":"1252_CR10","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10439-015-1380-x","volume":"44","author":"B O\u2019Brien","year":"2016","unstructured":"O\u2019Brien B, Zafar H, Ibrahim A, Zafar J, Sharif F (2016) Coronary stent materials and coatings: a technology and performance update. Ann Biomed Eng 44:523\u2013535","journal-title":"Ann Biomed Eng"},{"key":"1252_CR11","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jjcc.2011.07.004","volume":"58","author":"G Nakazawa","year":"2011","unstructured":"Nakazawa G (2011) Stent thrombosis of drug eluting stent: pathological perspective. J Cardiol 58:84\u201391","journal-title":"J Cardiol"},{"key":"1252_CR12","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.jacc.2011.01.011","volume":"57","author":"G Nakazawa","year":"2011","unstructured":"Nakazawa G, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, Ladich E, Kolodgie FD, Finn AV, Virmani R (2011) The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol 57:1314\u20131322","journal-title":"J Am Coll Cardiol"},{"key":"1252_CR13","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1136\/hrt.2010.198804","volume":"96","author":"T Jernberg","year":"2010","unstructured":"Jernberg T, Attebring MF, Hambraeus K, Ivert T, James S, Jeppsson A, Lagerqvist B, Lindahl B, Stenestrand U, Wallentin L (2010) The Swedish web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART). Heart 96:1617\u20131621","journal-title":"Heart"},{"key":"1252_CR14","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.amjcard.2013.12.011","volume":"113","author":"IT Meredith","year":"2014","unstructured":"Meredith IT, Teirstein PS, Bouchard A, Carrie D, Mollmann H, Oldroyd KG, Hall J, Allocco DJ, Dawkins KD, Stone GW (2014) Three-year results comparing platinum-chromium PROMUS element and cobalt-chromium XIENCE V everolimus-eluting stents in de novo coronary artery narrowing (from the PLATINUM Trial). Am J Cardiol 113:1117\u20131123","journal-title":"Am J Cardiol"},{"key":"1252_CR15","doi-asserted-by":"crossref","unstructured":"Kereiakes DJ, Meredith IT, Windecker S, Lee Jobe R, Mehta SR, Sarembock IJ, Feldman RL, Stein B, Dubois C, Grady T, Saito S, Kimura T, Christen T, Allocco DJ, Dawkins KD (2015) Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II Randomized Trial. Circ Cardiovasc Interv 8 e002372","DOI":"10.1161\/CIRCINTERVENTIONS.114.002372"},{"key":"1252_CR16","doi-asserted-by":"crossref","unstructured":"Danzi GB, Piccolo R, Chevalier B, Urban P, Fath-Ordoubadi F, Carrie D, Wiemer M, Serra A, Wijns W, Kala P, Stabile A, Goicolea Ruigomez J, Sagic D, Laanmets P, Strupp G, West N, Nobori I (2016) Five-year clinical performance of a biodegradable polymer-coated biolimus-eluting stent in unselected patients. Heart","DOI":"10.1136\/heartjnl-2016-309283"},{"key":"1252_CR17","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1093\/eurheartj\/ehu210","volume":"35","author":"S Saito","year":"2014","unstructured":"Saito S, Valdes-Chavarri M, Richardt G, Moreno R, Iniguez Romo A, Barbato E, Carrie D, Ando K, Merkely B, Kornowski R, Eltchaninoff H, James S, Wijns W, Investigators CI (2014) A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical evaluation of new terumo drug-eluting coronary stent system in the treatment of patients with coronary artery disease) trial. Eur Heart J 35:2021\u20132031","journal-title":"Eur Heart J"},{"key":"1252_CR18","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00392-015-0953-x","volume":"105","author":"S Cassese","year":"2016","unstructured":"Cassese S, Kufner S, Xhepa E, Byrne RA, Kreutzer J, Ibrahim T, Tiroch K, Valgimigli M, Tolg R, Fusaro M, Schunkert H, Laugwitz KL, Mehilli J, Kastrati A (2016) Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials. Clin Res Cardiol 105:575\u2013584","journal-title":"Clin Res Cardiol"},{"key":"1252_CR19","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1161\/CIRCULATIONAHA.111.063644","volume":"125","author":"LO Jensen","year":"2012","unstructured":"Jensen LO, Thayssen P, Hansen HS, Christiansen EH, Tilsted HH, Krusell LR, Villadsen AB, Junker A, Hansen KN, Kaltoft A, Maeng M, Pedersen KE, Kristensen SD, Botker HE, Ravkilde J, Sanchez R, Aaroe J, Madsen M, Sorensen HT, Thuesen L, Lassen JF, Scandinavian Organization for Randomized Trials With Clinical Outcome IVI (2012) Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the scandinavian organization for randomized trials with clinical outcome IV (SORT OUT IV). Circulation 125:1246\u20131255","journal-title":"Circulation"},{"key":"1252_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0140-6736(09)62127-9","volume":"375","author":"E Kedhi","year":"2010","unstructured":"Kedhi E, Joesoef KS, McFadden E, Wassing J, van Mieghem C, Goedhart D, Smits PC (2010) Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial. Lancet 375:201\u2013209","journal-title":"Lancet"},{"key":"1252_CR21","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1056\/NEJMoa1004130","volume":"363","author":"PW Serruys","year":"2010","unstructured":"Serruys PW, Silber S, Garg S, van Geuns RJ, Richardt G, Buszman PE, Kelbaek H, van Boven AJ, Hofma SH, Linke A, Klauss V, Wijns W, Macaya C, Garot P, DiMario C, Manoharan G, Kornowski R, Ischinger T, Bartorelli A, Ronden J, Bressers M, Gobbens P, Negoita M, van Leeuwen F, Windecker S (2010) Comparison of zotarolimus-eluting and everolimus-eluting coronary stents. N Engl J Med 363:136\u2013146","journal-title":"N Engl J Med"},{"key":"1252_CR22","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.jacc.2013.12.036","volume":"63","author":"M Taniwaki","year":"2014","unstructured":"Taniwaki M, Stefanini GG, Silber S, Richardt G, Vranckx P, Serruys PW, Buszman PE, Kelbaek H, Windecker S, Investigators RA-C (2014) 4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent with an Everolimus-Eluting Stent for Percutaneous Coronary Intervention). J Am Coll Cardiol 63:1617\u20131625","journal-title":"J Am Coll Cardiol"},{"key":"1252_CR23","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/S0140-6736(12)61223-9","volume":"380","author":"M Sabate","year":"2012","unstructured":"Sabate M, Cequier A, Iniguez A, Serra A, Hernandez-Antolin R, Mainar V, Valgimigli M, Tespili M, den Heijer P, Bethencourt A, Vazquez N, Gomez-Hospital JA, Baz JA, Martin-Yuste V, van Geuns RJ, Alfonso F, Bordes P, Tebaldi M, Masotti M, Silvestro A, Backx B, Brugaletta S, van Es GA, Serruys PW (2012) Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial. Lancet 380:1482\u20131490","journal-title":"Lancet"},{"key":"1252_CR24","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1001\/jama.2012.10065","volume":"308","author":"L Raber","year":"2012","unstructured":"Raber L, Kelbaek H, Ostojic M, Baumbach A, Heg D, Tuller D, von Birgelen C, Roffi M, Moschovitis A, Khattab AA, Wenaweser P, Bonvini R, Pedrazzini G, Kornowski R, Weber K, Trelle S, Luscher TF, Taniwaki M, Matter CM, Meier B, Juni P, Windecker S, Investigators CAT (2012) Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial. JAMA 308:777\u2013787","journal-title":"JAMA"},{"key":"1252_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jcin.2013.07.012","volume":"7","author":"M Sabate","year":"2014","unstructured":"Sabate M, Raber L, Heg D, Brugaletta S, Kelbaek H, Cequier A, Ostojic M, Iniguez A, Tuller D, Serra A, Baumbach A, von Birgelen C, Hernandez-Antolin R, Roffi M, Mainar V, Valgimigli M, Serruys PW, Juni P, Windecker S (2014) Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials. JACC Cardiovasc Interv 7:55\u201363","journal-title":"JACC Cardiovasc Interv"},{"key":"1252_CR26","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1016\/j.jacc.2015.04.017","volume":"65","author":"T Palmerini","year":"2015","unstructured":"Palmerini T, Benedetto U, Biondi-Zoccai G, Della Riva D, Bacchi-Reggiani L, Smits PC, Vlachojannis GJ, Jensen LO, Christiansen EH, Berencsi K, Valgimigli M, Orlandi C, Petrou M, Rapezzi C, Stone GW (2015) Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis. J Am Coll Cardiol 65:2496\u20132507","journal-title":"J Am Coll Cardiol"},{"key":"1252_CR27","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.jacc.2010.07.016","volume":"56","author":"DR Holmes Jr","year":"2010","unstructured":"Holmes DR Jr, Kereiakes DJ, Garg S, Serruys PW, Dehmer GJ, Ellis SG, Williams DO, Kimura T, Moliterno DJ (2010) Stent thrombosis. J Am Coll Cardiol 56:1357\u20131365","journal-title":"J Am Coll Cardiol"},{"key":"1252_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00392-016-1035-4","volume":"106","author":"SY Lee","year":"2017","unstructured":"Lee SY, Hong MK, Shin DH, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Kim HS, Valgimigli M, Palmerini T, Stone GW (2017) Clinical outcomes of dual antiplatelet therapy after implantation of drug-eluting stents in patients with different cardiovascular risk factors. Clin Res Cardiol 106:165\u2013173","journal-title":"Clin Res Cardiol"},{"key":"1252_CR29","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","volume":"357","author":"SD Wiviott","year":"2007","unstructured":"Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM, Investigators T-T (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357:2001\u20132015","journal-title":"N Engl J Med"},{"key":"1252_CR30","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA, Investigators P, Freij A, Thorsen M (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361:1045\u20131057","journal-title":"N Engl J Med"},{"key":"1252_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/ehjcvp\/pvv034","volume":"2","author":"A Sahlen","year":"2016","unstructured":"Sahlen A, Varenhorst C, Lagerqvist B, Renlund H, Wallentin L, James SK, Jernberg T (2016) Contemporary use of ticagrelor in patients with acute coronary syndrome: insights from Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). Eur Heart J Cardiovasc Pharmacother 2:5\u201312","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"1252_CR32","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.jcin.2015.08.013","volume":"8","author":"R Piccolo","year":"2015","unstructured":"Piccolo R, Pilgrim T, Heg D, Franzone A, Rat-Wirtzler J, Raber L, Silber S, Serruys PW, Juni P, Windecker S (2015) Comparative effectiveness and safety of new-generation versus early-generation drug-eluting stents according to complexity of coronary artery disease: a patient-level pooled analysis of 6,081 Patients. JACC Cardiovasc Interv 8:1657\u20131666","journal-title":"JACC Cardiovasc Interv"},{"key":"1252_CR33","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1056\/NEJMoa1607991","volume":"375","author":"KH Bonaa","year":"2016","unstructured":"Bonaa KH, Mannsverk J, Wiseth R, Aaberge L, Myreng Y, Nygard O, Nilsen DW, Klow NE, Uchto M, Trovik T, Bendz B, Stavnes S, Bjornerheim R, Larsen AI, Slette M, Steigen T, Jakobsen OJ, Bleie O, Fossum E, Hanssen TA, Dahl-Eriksen O, Njolstad I, Rasmussen K, Wilsgaard T, Nordrehaug JE, Investigators N (2016) Drug-eluting or bare-metal stents for coronary artery disease. N Engl J Med 375:1242\u20131252","journal-title":"N Engl J Med"},{"key":"1252_CR34","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/eurheartj\/ehr479","volume":"33","author":"G Sarno","year":"2012","unstructured":"Sarno G, Lagerqvist B, Frobert O, Nilsson J, Olivecrona G, Omerovic E, Saleh N, Venetzanos D, James S (2012) Lower risk of stent thrombosis and restenosis with unrestricted use of \u2018new-generation\u2019 drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Eur Heart J 33:606\u2013613","journal-title":"Eur Heart J"},{"key":"1252_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jacc.2014.04.022","volume":"64","author":"G Sarno","year":"2014","unstructured":"Sarno G, Lagerqvist B, Nilsson J, Frobert O, Hambraeus K, Varenhorst C, Jensen UJ, Todt T, Gotberg M, James SK (2014) Stent thrombosis in new-generation drug-eluting stents in patients with STEMI undergoing primary PCI: a report from SCAAR. J Am Coll Cardiol 64:16\u201324","journal-title":"J Am Coll Cardiol"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00392-018-1252-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-018-1252-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-018-1252-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T17:18:16Z","timestamp":1604164696000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00392-018-1252-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,17]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["1252"],"URL":"https:\/\/doi.org\/10.1007\/s00392-018-1252-0","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,17]]},"assertion":[{"value":"6 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.V. reports during the conduct of this work, institutional research grants from AstraZeneca and The Medicines Company, lecture and advisory board fees from AstraZeneca, The Medicines Company and Boeringer Ingelheim, lecture fees from Bayer, CSL Behring, Bristol Myers Squibb, and Pfizer and is on the Clinical Endpoint Committee for Pfizer, Bristol Myers Squibb, Philips and AstraZeneca. At the time of resubmission of a revised version of this manuscript C.V reports being a Pfizer employee. M.L. reports no conflicts of interest. G.S. reports institutional research grant from Boston Scientific. G.O. reports physician proctor for Edwards Lifesciences and EPS Vascular, lecture fees from Biotronik, BBraun, advisory board fees for Vascular Solutions and is on the Clinical Endpoint Committee for Biosensors. U.J reports no conflicts of interest. J.N. reports no conflicts of interest. J.C. reports lecture fees from BBraun. S.J. reports institutional research grants and honoraria from Boston Scientific, Abbot vascular and Biotronic. B.L reports institutional grant from AstraZeneca.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}